305 related articles for article (PubMed ID: 30940109)
41. LAPTM4B down regulation inhibits the proliferation, invasion and angiogenesis of HeLa cells in vitro.
Meng F; Chen X; Song H; Lou G
Cell Physiol Biochem; 2015; 37(3):890-900. PubMed ID: 26383850
[TBL] [Abstract][Full Text] [Related]
42. Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors.
Chang HC; Chen YM; Tseng CC; Huang KT; Wang CC; Chen YC; Lai CH; Fang WF; Kao HC; Lin MC
Tumour Biol; 2017 Mar; 39(3):1010428317695939. PubMed ID: 28351317
[TBL] [Abstract][Full Text] [Related]
43. A novel diagnostic system to evaluate epidermal growth factor receptor impact as a prognostic and therapeutic indicator for lung adenocarcinoma.
Takakuwa K; Mogushi K; Han M; Fujii T; Hosoya M; Yamanami A; Akita T; Yamashita C; Hayashida T; Kato S; Yamaguchi S
Sci Rep; 2020 Apr; 10(1):6214. PubMed ID: 32277151
[TBL] [Abstract][Full Text] [Related]
44. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
45. Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer.
Zhang X; Ren D; Guo L; Wang L; Wu S; Lin C; Ye L; Zhu J; Li J; Song L; Lin H; He Z
Breast Cancer Res; 2017 Feb; 19(1):15. PubMed ID: 28179017
[TBL] [Abstract][Full Text] [Related]
46. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A
Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738
[TBL] [Abstract][Full Text] [Related]
47. LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma.
Zhai G; Yan K; Ji X; Xu W; Yang J; Xiong F; Su J; McNutt MA; Yang H
PLoS One; 2012; 7(9):e45290. PubMed ID: 22984631
[TBL] [Abstract][Full Text] [Related]
48. CircRNA has_circ_0001946 promotes cell growth in lung adenocarcinoma by regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin signaling pathway.
Yao Y; Hua Q; Zhou Y; Shen H
Biomed Pharmacother; 2019 Mar; 111():1367-1375. PubMed ID: 30841451
[TBL] [Abstract][Full Text] [Related]
49. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
[TBL] [Abstract][Full Text] [Related]
50. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of MTFR1 promotes cancer progression and drug-resistance on cisplatin and is related to the immune microenvironment in lung adenocarcinoma.
Li QY; Guo Q; Luo WM; Luo XY; Ji YM; Xu LQ; Guo JL; Shi RS; Li F; Lin CY; Zhang J; Ke D
Aging (Albany NY); 2024 Jan; 16(1):66-88. PubMed ID: 38170222
[TBL] [Abstract][Full Text] [Related]
52. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.
Li S; Wang L; Meng Y; Chang Y; Xu J; Zhang Q
Oncotarget; 2017 Jun; 8(25):41282-41293. PubMed ID: 28476037
[TBL] [Abstract][Full Text] [Related]
53. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
54. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
55. LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma.
Yang H; Zhai G; Ji X; Xiong F; Su J; McNutt MA
PLoS One; 2012; 7(4):e34984. PubMed ID: 22509374
[TBL] [Abstract][Full Text] [Related]
56. Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma.
Yuan W; Zhang X; Xu Y; Li S; Hu Y; Wu S
Mol Carcinog; 2014 Jan; 53(1):49-57. PubMed ID: 22911672
[TBL] [Abstract][Full Text] [Related]
57. CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.
Ishibashi M; Neri S; Hashimoto H; Miyashita T; Yoshida T; Nakamura Y; Udagawa H; Kirita K; Matsumoto S; Umemura S; Yoh K; Niho S; Tsuboi M; Masutomi K; Goto K; Ochiai A; Ishii G
Sci Rep; 2017 Apr; 7():46662. PubMed ID: 28429795
[TBL] [Abstract][Full Text] [Related]
58. The prognostic effect of the epidermal growth factor receptor gene mutation on recurrence dynamics of lung adenocarcinoma.
Park IK; Hyun K; Kim ER; Park S; Kang CH; Kim YT
Eur J Cardiothorac Surg; 2018 Dec; 54(6):1022-1027. PubMed ID: 29878144
[TBL] [Abstract][Full Text] [Related]
59. Helicobacter pylori infection promotes epithelial-to-mesenchymal transition of gastric cells by upregulating LAPTM4B.
Zhou S; Chen H; Yuan P; Shi N; Wang X; Hu J; Liu L
Biochem Biophys Res Commun; 2019 Jun; 514(3):893-900. PubMed ID: 31084933
[TBL] [Abstract][Full Text] [Related]
60. Lentivirus-mediated disintegrin and metalloproteinase 17 RNA interference reversed the acquired resistance to gefitinib in lung adenocarcinoma cells in vitro.
Li YQ; Liu YS; Ying XW; Zhou HB; Wang Z; Wu SC; Yan JP; Jing YT; Yang Y
Biotechnol Prog; 2018 Jan; 34(1):196-205. PubMed ID: 28960861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
